SANUWAVE Health, Inc. (SNWV), our long term holding, has received a patent issued by the U.S. Patent and Trademark Office entitled “Extracorporeal Shock Wave Device.” The claims of the patent (patent number 8,556,813) relate to a new extracorporeal applicator, which creates significant advantages for certain applications. The patent has a term extending to April 2031. […]
We sent email to our subscribers on August 29th with our new break-out pick: Advaxis (ADXS). Congratulations to all who followed our alert – ADXS‘s share price doubled in less than 2 weeks! Email: ADXS Breaks Resistance and Set To Rally Advaxis made a strong move on Thursday, despite the typical quiet week of trading before […]
Sanuwave (SNWV) stated that enrollment for the last part of their phase III study of ‘dermaPACE’ is set to begin before the end of Q2 – which is less than 30 days away. This is a huge catalyst for the company’s shares, which have traded completely under the radar thus far. dermaPACE is a device […]
“Must-Read” review from BiotechIntel Novo Nordisk – the world’s largest insulin producer – and major diabetes drug manufacturers – could see BILLIONS in recurring revenue dry up as a small, California-based biotech company advances a technology that promises to change diabetes treatment. Over $100,000,000 has been invested in developing this super-drug that threatens to make […]
Antriabio – which trades under the ticker “ANTB” – is about to bounce. If you’ve been following what I have to say I also think ANTB has 10-bagger potential (more about that in a moment). According to otcshortreport.com, about 50% of the shares that have traded in the last 30 days were sold short. A […]
ARCA Biopharma (ABIO) has been alerted as day-trading investment opportunity in real-time to our Twitter & Facebook followers at an around $.50/share. ABIO stock closed at $.68/share for the solid 36% in day-trading gains. Yesterday ABIO announced an update on a proposed, genetically-targeted clinical trial in atrial fibrillation (“AF”) of the Company’s lead developmental drug, Gencaro […]
edited on 02/02/2013: AntriaBio, Inc. (“AntriaBio”) announced that FINRA has approved a change of the Company’s stock ticker symbol. Effective today, the Company’s common shares will commence trading on the OTC Bulletin Board under the trading symbol “ANTB” ( OTCQB : ANTB ). The previous trading symbol was “FMYY” ( OTCQB : FMYY ). AntriaBio, […]
Implant Sciences develops and manufactures explosive trace detection sensors and systems that are capable of detecting minute amounts of a wide variety of military, commercial, and homemade explosives. IMSC’s patented technologies provide unique screening capabilities to extend and improve counter-terrorist and homeland security efforts. Read our due diligence report from the last year here. Yesterday, […]
Sophisticated traders must take a look at iBio, Inc. (IBIO) as it seems that company has been overlooked as a solid player on the flu market. The high level of flu cases being reported across all states in the USA and Europe. Only in New York state a flu epidemic has hit more than 19,000 […]
Zoom Technologies (ZOOM) has been alerted on Twitter, as a trading opportunity, after company’s announcement of the execution of a definitive agreement pursuant to which it will sell its China-based manufacturing, sales and marketing, and R&D subsidiaries, and that the proceeds of the sale will be used for the purchase of additional U.S.-based businesses. Zoom […]
